BackPharming Group N.V. Overview
Pharming Group N.V. - ADR

Pharming Group N.V. Target Price

Analysts' average 12-month price target for Pharming Group N.V. is $40.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.23

Average Target Price

$40.00256.2% upside

1 analysts in the last 4 months

High: $40 | Low: $40

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-08Oppenheimer$40256.2% upsideOpen
2026-04-10Canaccord GenuityWhitney Ijem$37229.5% upsideOpen
2026-03-12H.C. WainwrightJoseph Pantginis$37229.5% upsideOpen
2025-11-07Oppenheimer$42274% upsideOpen
2024-12-09JefferiesLucy Codrington$1424.7% upsideOpen

Pharming Group N.V. (PHAR) FAQ

As of the most recent data, PHAR shows a target price of $40. Scroll down for historical charts and peer comparison views.

If Pharming Group N.V. moved to the average analyst target of $40, shares would be roughly 256.2% higher than $11.23. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Pharming Group N.V.'s earnings trajectory.

Besides this target price page, Stockcircle has Pharming Group N.V.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $40) with ownership activity and broader fundamentals.

Pharming Group N.V.'s target price is $40; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.